Exagen (XGN) Profit After Tax Growth (3y) (2021 - 2026)
Exagen (XGN) Profit After Tax Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 8.53% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | -1.85% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 14.70% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 3.93% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -4.58% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 13.70% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 42.35% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 6.28% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 10.28% |
| 10 | Exagen | 156.59 Mn | 131.99 Mn | 12.22 Mn | 13.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.93% |
| Mar 31, 2026 | 19.79% |
| Dec 31, 2025 | 31.21% |
| Sep 30, 2025 | 4.34% |
| Jun 30, 2025 | 32.86% |
| Mar 31, 2025 | 28.52% |
| Dec 31, 2024 | 18.91% |
| Sep 30, 2024 | 11.19% |
| Jun 30, 2024 | 22.65% |
| Mar 31, 2024 | 18.51% |
| Dec 31, 2023 | -17.30% |
| Sep 30, 2023 | -7.92% |
| Jun 30, 2023 | -14.23% |
| Mar 31, 2023 | -11.39% |
| Dec 31, 2022 | 12.80% |
| Sep 30, 2022 | -37.11% |
| Jun 30, 2022 | -73.97% |
| Mar 31, 2022 | -56.03% |
| Dec 31, 2021 | -74.96% |
| Sep 30, 2021 | -59.90% |